Euro-Med Laboratories Phil., Inc. (PSE:EURO)
Philippines flag Philippines · Delayed Price · Currency is PHP
0.8700
+0.0400 (4.82%)
At close: May 9, 2025, 2:45 PM PST

PSE:EURO Ratios and Metrics

Millions PHP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3,4953,3723,0843,5785,7579,622
Upgrade
Market Cap Growth
9.33%9.33%-13.79%-37.86%-40.17%46.25%
Upgrade
Enterprise Value
6,6976,4366,1596,4278,75411,561
Upgrade
Last Close Price
0.850.820.700.781.212.02
Upgrade
PE Ratio
10.639.9910.6417.9034.0645.81
Upgrade
PS Ratio
0.600.580.590.851.612.51
Upgrade
PB Ratio
0.590.570.530.631.021.77
Upgrade
P/TBV Ratio
0.620.600.550.661.071.86
Upgrade
P/FCF Ratio
68.9066.4749.5460.2828.38-
Upgrade
P/OCF Ratio
14.1613.668.7124.1411.7921.83
Upgrade
EV/Sales Ratio
1.161.111.171.522.443.02
Upgrade
EV/EBITDA Ratio
6.716.936.929.6813.7015.15
Upgrade
EV/EBIT Ratio
10.019.629.4414.5921.3021.38
Upgrade
EV/FCF Ratio
132.01126.8698.92108.2943.16-
Upgrade
Debt / Equity Ratio
0.730.730.690.650.610.66
Upgrade
Debt / EBITDA Ratio
4.304.304.255.064.964.45
Upgrade
Debt / FCF Ratio
84.6284.6264.8762.0216.87-
Upgrade
Asset Turnover
0.530.530.510.430.360.38
Upgrade
Inventory Turnover
2.202.202.091.951.621.73
Upgrade
Quick Ratio
0.780.780.710.690.710.60
Upgrade
Current Ratio
1.361.361.311.331.331.13
Upgrade
Return on Equity (ROE)
5.76%5.76%5.02%3.52%3.05%3.85%
Upgrade
Return on Assets (ROA)
3.85%3.85%3.92%2.79%2.60%3.31%
Upgrade
Return on Capital (ROIC)
4.17%4.17%4.23%2.98%2.84%3.67%
Upgrade
Return on Capital Employed (ROCE)
9.50%9.50%9.50%6.50%6.10%8.70%
Upgrade
Earnings Yield
9.66%10.01%9.40%5.59%2.94%2.18%
Upgrade
FCF Yield
1.45%1.50%2.02%1.66%3.52%-0.10%
Upgrade
Dividend Yield
7.06%-8.57%4.51%1.66%0.74%
Upgrade
Payout Ratio
73.07%73.07%49.64%72.00%-97.89%
Upgrade
Total Shareholder Return
7.06%-8.57%4.51%1.66%0.74%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.